DEPO PROVERA 150 mg/3 ml, suspension for injection (deep intramuscular) bottle, 3 ml
Active ingredients: Medroxyprogesterone acetate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionbottle, 3 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEPO PROVERA 150 mg/3 mL, suspension injectable (intramusculaire profonde)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) de 3 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jul 1983
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62429736CIP73238699CIP133400932386994Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE MÉDROXYPROGESTÉRONEsuspension | 150 mg · 3 ml de suspension injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.